v3.26.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Equity Shares not Included in Computation of EPS

Potentially dilutive securities not included in the computation of loss per share for the years ended December 31, 2025 and 2024 are as follows:

 

   2025   2024 
   For the years ended December 31, 
   2025   2024 
Outstanding options to purchase common stock   657,042    108,955 
Warrants to purchase shares of common stock, IPO   500    500 
Warrants to purchase shares of common stock, May 2023 offering   424    424 
Warrants to purchase shares of common stock, November 2023 offering   20,000    20,000 
Warrants to purchase shares of common stock, June 2024 PIPE   100,341    329,771 
Warrants to purchase shares of common stock, December 2024 PIPE   163,048    480,721 
Placement agent warrants, June 2024 PIPE   39,573    39,573 
Placement agent warrants, December 2024 PIPE   57,687    57,687 
Warrants to purchase shares of common stock, June 2025 PIPE   1,594,570    - 
Warrants to purchase shares of common stock, July 2025 PIPE   45,592    - 
Placement agent warrants, June 2025 PIPE   177,362    - 
Placement agent warrants, July 2025 PIPE   52,128    - 
Warrants to purchase shares of common stock, July 2025 RDO   744,522    - 
Strategic advisor warrants, November 2025 offering   10,318,215    - 
Total potentially dilutive securities   13,971,004    1,037,631